𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term Follow-up Outcome of Patients Undergoing Radiofrequency Ablation for Unresectable Hepatocellular Carcinoma

✍ Scribed by Junji Machi; Racquel S. Bueno; Linda L. Wong


Publisher
Springer
Year
2005
Tongue
English
Weight
117 KB
Volume
29
Category
Article
ISSN
0364-2313

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Long-term follow-up of 24 patients under
✍ William P. Shutze; Jonathan Sack; Joaquin S. Aldrete πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 432 KB πŸ‘ 1 views

Potentially curative radical pancreaticoduodenectomy for ampullary adenocarcinoma was performed in 24 patients over a 35-year period. The overall operative mortality was 12.5%. Actuarial survival rate at 5 years was 61% f 13.4 standard error of the mean (SEM) and subsequently remained unchanged. In

Repeated radiofrequency ablation for man
✍ Sandro Rossi; Valentina Ravetta; Laura Rosa; Giorgia Ghittoni; Francesca Torello πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 462 KB

In most patients with cirrhosis, successful percutaneous ablation or surgical resection of hepatocellular carcinoma (HCC) is followed by recurrence. Radiofrequency ablation (RFA) has proven effective for treating HCC nodules, but its repeatability in managing recurrences and the impact of this appro

Radiofrequency ablation of hepatocellula
✍ GisΓ¨le N'Kontchou; Amel Mahamoudi; Mounir Aout; Nathalie Ganne-CarriΓ©; VΓ©ronique πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 341 KB

For the treatment of small hepatocellular carcinoma (HCC), radiofrequency ablation (RFA) is in some centers considered a first-line therapeutic option. However, such a strategy is still under debate with regard to tumor and patient characteristics. In this single-center study we assessed the 5-year